Latest Capital Raises News

Centrex Limited has updated the timetable for its $10.4 million Entitlement Offer, with the offer opening on 28 January and closing on 19 February 2025. The company aims to bolster its position in sustainable agriculture through this capital raise.

Askari Metals has closed a $350,000 strategic placement with Celtic Finance Corp. to advance its growing uranium portfolio in Tanzania, shifting away from a previously planned Rights Issue.

Vonex Limited has terminated its proposed scheme with Maxo Telecommunications amid shareholder opposition, while MaxoTel’s 4.4c cash offer will close on January 28, 2025. The Vonex Board recommends shareholders accept MaxoTel’s offer and reject Swoop Telecommunications’ conditional scrip bid.

Horizon Oil has successfully completed the WM29 well and commenced drilling WM30 in the Mereenie Development Program, aiming to boost gas production and meet new Northern Territory gas sales commitments.

North Stawell Minerals has launched its 2025 diamond drilling program targeting significant gold mineralisation at the Wildwood and Darlington prospects in Victoria, backed by a recent $1.3 million capital raise.

Green Critical Minerals Limited (ASX: GCM) has temporarily paused trading of its securities, signaling an impending announcement that investors should watch closely.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.

Sipa Resources has inked agreements to acquire four advanced gold projects in South Australia and Western Australia, positioning itself for a significant exploration boost. The $2.2 million deal, coupled with a $1.75 million capital raise, signals a strategic pivot towards expanding its resource base.

GreenTech Metals has restarted its stage 2 diamond core drilling at the Whundo Cu-Zn project in West Pilbara, backed by a completed $2.3 million placement to fund exploration and resource expansion efforts.

Resources & Energy Group Ltd (REZ) has clarified recent trading activity in its shares, attributing the surge to a significant rise in gold prices rather than undisclosed information. The company remains focused on its Maranoa gold recovery program, with further results pending.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.

Arafura Rare Earths has locked in a A$200 million convertible note investment from the National Reconstruction Fund Corporation, marking a pivotal step toward developing Australia's first ore-to-oxide rare earths processing operation at Nolans.